WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticoagulant_Master_CMAP_v5, Time to the first occurrence of Non-CNS systemic embolism (SEE) hasObservation CRF: Non-CNS systemic embolism (SEE), CRF: Non-CNS systemic embolism (SEE) asObservationTime Date/Time of occurrence, Composite endpoint hasObservation Individual secondary endpoints, Anticoagulant endpoint hasObservation Secondary efficacy endpoint, Primary efficacy endpoints are denoted by bold font, Primary efficacy endpoints hasOutcomeAssessment Time to the first occurrence of stroke, Secondary efficacy endpoint hasOutcomeAssessment Net clinical benefit (NCB), Secondary efficacy endpoints are denoted by italics font, CRF: Stroke asObservationTime Date/Time of occurrence, Concepts (e.g. Subgroup, NCB) are denoted by solid round-edged rectangle, Safety endpoint hasObservation CRF: Adverse event (AE)s, Secondary efficacy endpoint hasOutcomeAssessment Individual endpoint, Net clinical benefit (NCB) hasObservation Individual secondary endpoints, Anticoagulant endpoint hasObservation Safety endpoint, Therapeutic Efficacy Point has Observation or Assessment, Repeated concepts/instances (e.g. Stroke, Death) are denoted by dotted outline, CRF: Non-CNS systemic embolism (SEE) asObservationTime Date/Time of end of trial, CRF: Stroke asObservationTime Date/Time of end of trial, Hepatotoxicity hasOutcomeAssessment Liver function test (LFT), Individual endpoint hasObservation Individual secondary endpoints